QF
MYOV

QVT Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

QVT Financial’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-37,231,342
Closed -$471M – 66
2017
Q4 		$471M Hold
37,231,342
– – 26.56% 1
2017
Q3 		$576M Hold
37,231,342
– – 21.46% 1
2017
Q2 		$436M Hold
37,231,342
– – 11.63% 2
2017
Q1 		$437M Hold
37,231,342
– – 13.57% 2
2016
Q4 		$463M Buy
+37,231,342
New +$431M 14.07% 3

Other funds holding MYOV

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

QVT Financial's MYOV Position: Q1 2018 in Review

QVT Financial sold out of Myovant Sciences Ltd. (MYOV) in Q1 2018, closing a stake of 37,231,342 shares — an estimated $471M sold.

QVT Financial first reported a position in MYOV in Q4 2016 and held it in 5 quarters. The position peaked at $576M in Q3 2017. 32 funds tracked by Wall St. Rank hold MYOV as of Q1 2018.

  • QVT Financial reported no remaining Myovant Sciences Ltd. position as of Q1 2018 after selling out during the quarter.
  • QVT Financial sold 37,231,342 Myovant Sciences Ltd. shares in Q1 2018, an estimated $471M.
  • QVT Financial first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 5 quarters.
  • QVT Financial's Myovant Sciences Ltd. position peaked at $576M in Q3 2017.
  • 32 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2018.

Based on QVT Financial's 13F filing for Q1 2018, filed 15 May 2018.